Share:

Top Back to top

2023 Election Results

by
EBMT Organization
//
Severe Aplastic Anaemia Working Party (SAAWP)
Paediatric Diseases Working Party (PDWP)
Haemoglobinopathies Working Party (HWP)

All eligible to vote Principal Investigators (579) from EBMT full membership centres were invited to vote online for the nominated, endorsed and approved EBMT Treasurer and Working Party Chair candidates for 2023, in addition to approving the activity reports (President, Secretary and Treasurer).

Voting took place online from Tuesday 11 April, 10h00 CEST until Monday 24 April 2023, 20h00 CEST.

192 ballots submitted of 579 eligible voters = 33% participation.


Please see the results of this online elections below:

EBMT Treasurer

Mette Hazenberg

 

EBMT Treasurer - Mette Hazenberg

Yes - I approve the candidate 170 votes (97.14%)
No - I reject the candidate 5 votes (2.86%)

 

Yes - I approve the candidate wins with 97.14% of the vote. (175 votes tallied and 17 abstentions)

"It is a great honour to be elected to the Executive Committee of EBMT. To optimize the advancement of cell therapies it will be important to continue to work closely with donors and patients, include novel tools such as patient-reported outcomes measures, continue our scientific work as a community and address age- and gender-specific issues faced by patients. Major challenges for the future are amongst others improving equality, diversity and inclusion, and the costs of novel cell therapies. By addressing these and other issues, we can, as a community, fulfil our responsibility to ensure access to therapy for all who are in need."

 

EBMT Working Party Chairs

Antonio Risitano

 

EBMT Severe Aplastic Anaemia Working Party Chair - Antonio Risitano

 

Yes - I approve the candidate 172 votes (96.09%)
No - I reject the candidate 7 votes (3.91%)
 

Yes - I approve the candidate wins with 96.09% of the vote. (179 votes tallied and 13 abstentions)

"It’s an honour and a privilege for me to have been selected as the new SAAWP Chair, as it was in the past 19 years of being part of this community. I have been so lucky to grow up scientifically thanks to several Masters met within the SAAWP. I had the opportunity to contribute to science conducted by the SAAWP, and our recent Phase III RACE study represents a milestone for our field. Today, I’m highly motivated to continue my work for the SAAWP, serving as chairman for the next 4 years, and continuing the long-lasting scientific tradition of this group of friends and colleagues."

 

Krzysztof Kalwak

 

EBMT Paediatric Diseases Working Party Chair - Krzysztof Kalwak

Krzysztof Kalwak 72 votes (51.43%)
Petr Sedlacek 68 votes (48.57%)
  Krzysztof Kalwak wins with 51.43% of the vote. (140 votes tallied and 52 abstentions)

"It is a great honour to have been elected as the new Chair of the EBMT PDWP. The efforts of our Pediatric Diseases Working Party to harmonize practices across Europe and to promote European guidelines in pediatric HSCT and cellular therapy are projects that were initiated over the last years and I am eager to continue this work and fully support the ongoing projects aiming for an international consensus. 

It is pivotal for the WP to engage strongly with pediatric transplant colleagues across countries and continents to develop our ambitious goals. Our success will be dependent heavily on our capabilities to work as a team. 

“Together we can move the mountains”."

 

Emanuele Angelucci

 

EBMT Haemoglobinopathies Working Party Chair - Emanuele Angelucci

 

Emanuele Angelucci 92 votes (56.10%)
Josu de la Fuente 72 votes (43.90%)

 

Emanuele Angelucci wins with 56.10% of the vote. (164 votes tallied and 28 abstentions)

"I am honoured and grateful to have been elected the WP Chair of the new EBMT Hemoglobinopathies Working Party which should (and will) have an important role in supporting and enabling innovative approaches that can contribute to major advances in cellular and gene therapies in haemoglobin diseases.

The close collaboration between the WPs with clinical centres, laboratory facilities, founding agencies, pharma and hemoglobinopathies doctors and associations must be instrumental to continuing improving available and new therapies and optimizing treatment for our patients.

I am fully committed to working to strengthen the existing collaborations, promoting new ones and delivering excellence in patient care, education, and research."


EBMT Activity Reports and Bylaw Amendment

In addition to voting online for the nominated candidates, PIs were also asked to approve the President's, Secretary's and the Treasurer's reports and the Bylaw Amendment Approval of Articles 5 and 6, in advance of the Annual General Assembly Meeting 2023.

EBMT President's Activity Report 2022

Yes - I approve the President's Activity Report 2022 185 votes (99.46%)
No - I reject the President's Activity Report 2022 1 votes (0.54%)

 

Yes - I approve the President's Activity Report 2022 wins with 99.46% of the vote. (186 votes tallied and 6 abstentions)

EBMT Treasurer's Annual Report for 2022

Yes - I approve the Treasurer's Annual Report for 2022 176 votes (98.32%)
No - I reject the Treasurer's Annual Report for 2022 3 votes (1.68%)

 

Yes - I approve the Treasurer's Annual Report for 2022 wins with 98.32% of the vote. (179 votes tallied and 13 abstentions)

EBMT Secretary's Annual Report for 2022

Yes - I approve the Secretary's Annual Report for 2022 175 votes (98.31%)
No - I reject the Secretary's Annual Report for 2022 3 votes (1.69%)

 

Yes - I approve the Secretary's Annual Report for 2022 wins with 98.31% of the vote. (178 votes tallied and 14 abstentions)

Bylaw Amendment Approval of Articles 5 and 6

Yes - I approve the amendments 176 votes (96.70%)
No - I reject the amendments 6 votes (3.30%)

 

Yes - I approve the amendments wins with 96.70% of the vote. (182 votes tallied and 10 abstentions)

 


Outgoing Board Members

We would like to thank the following outgoing Board Members for their support and commitment to the Scientific Council and Board of Association during their mandates:

Harry Dolstra, EBMT Treasurer, member of the EBMT Executive Committee and member of the Board of Association 2019-2023.

Régis Peffault de la Tour, EBMT Severe Aplastic Anaemia Working Party Chair from 2019-2023. Co-Chair of the EBMT Scientific Council with the Research and Sciences Portfolio and member of the Board of Association from 2021-2023.

Selim Corbacioglu, EBMT Paediatric Diseases Working Party Chair from 2019-2023. Chair of the EBMT Scientific Council with the Research and Sciences Portfolio and member of the Board of Association from 2019-2023.